TrialsgrambetaRCTs are beautiful

ISIS-2

1988

Second International Study of Infarct Survival

In 17,187 patients with suspected acute myocardial infarction, aspirin plus intravenous streptokinase reduced 5-week vascular mortality compared with placebo.

Result

Vascular mortality at 5 weeks
Absolute difference
5.2 points

The absolute difference is derived from the event rates.

Also reported: Aspirin and streptokinase each independent.

Original publication
Subtopic
Reperfusion
Design
2×2 factorial RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
ISIS-2 Collaborative Group. Lancet. 1988;332(8607):349-360.doi 10.1016/S0140-6736(88)92833-4

Discussion & critique

Predates primary PCI; defined the role of aspirin in MI and is the reason every chest-pain patient gets chewable aspirin. Streptokinase has been superseded by fibrin-specific lytics and primary PCI, but the aspirin signal still anchors modern ACS care.

Discussed in podcasts